Clinical Trial Update: Effect of LEO 90100 on the HPA Axis and Calcium Metabolism in Subjects With Extensive Psoriasis VulgarisExtensive Psoriasis Vulgaris [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial evaluated the effects of LEO 90100 on the HPA axis and calcium metabolism in individuals with extensive psoriasis vulgaris; the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• LEO 90100

Snippet

Sponsor: LEO Pharma | Conditions: Psoriasis Vulgaris | Phase 2 | Status: COMPLETED | Results posted: 2016-09-16